About Merck
Merck is a publicly listed company based in Darmstadt (Germany) founded in 1668. Merck is engaged in science and technology solutions globally. It operates on a Professional Services and Direct-to-Consumer (D2C) model. The company has 376 employees. Merck has completed 18 acquisitions, including AmpTec, Ares Serono and Azem. Its website merckgroup.com draws about 911 thousand monthly visits. Merck offers products and services including Life Science Solutions, Healthcare Solutions, and Electronics Materials. Its focus areas include Pharmaceuticals, Biotechnology, Technology and Electronics. Its legal entity is Merck KGaA.
Company details
Merck is recognized as a leader in science and technology, focusing on Electronics, Healthcare, and Life Science sectors. Solutions are developed to address major illnesses, advance technological innovations, and support scientific research. Operations are conducted across 65 countries, with efforts centered on sustainability and digitalization. Partnerships and internal innovations are prioritized to elevate humanity and create a healthier future.
- Headquarters Darmstadt, Germany
- Employees 376
- Stage Public
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website merckgroup.com
- Social LinkedIn X Facebook Instagram
- Legal Name Merck Kgaa
- Annual Revenue$21.98 B (USD)0.78as on Dec 31, 2024
- Net Profit$2.89 B (USD)-1.66as on Dec 31, 2024
- EBITDA$6.41 B (USD)5.89as on Dec 31, 2024
- Latest Funding Round$271.17K (USD), Grant
Aug 2023
- InvestorsEuropean Union
& 3 more
- Employee Count376
- Investments & AcquisitionsAmpTec
& 17 more
Associated legal entities of Merck
Merck is associated with 4 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Merck Performance Materials Private Limited CIN U51900MH1987PTC043235 | Active | 23 Apr 1987 | Mumbai, Maharashtra, India | View details | |||
| Merck Specialities Private Limited CIN U24100MH2005PTC152680 | Active | 18 Apr 2005 | Mumbai, Maharashtra | ₹1,027 Cr | 818 | 3 | View details |
| Merck Life Science Private Limited CIN U33100MH1986PTC221693 | Active | 03 Sep 1986 | Mumbai, Maharashtra | ₹2,200 Cr | 618 | 2 | View details |
| Merck Performance Materials Private Limited CIN U46521MH1987PTC043235 | Active | 23 Apr 1987 | Mumbai, Maharashtra | ₹184 Cr | 48 | 2 | View details |
Products & Services of Merck
Merck offers a comprehensive portfolio of products and services, including Life Science Solutions, Healthcare Solutions, and Electronics Materials.
Tools and services for scientific research are provided.
Innovative treatments for various medical conditions are developed.
Advanced materials for tech industries are manufactured here.
Funding Insights of Merck
- Total Rounds 34
- Last Round Grant — $271,173
- First Round $11,048
(Jan 2014)
- Investors Count 4
Latest 10 of 34 funding rounds of Merck with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | $271,173 | Grant | – | – | |
| Aug 2023 | $240,740 | Grant | – | – | |
| Dec 2022 | $53,837 | Grant | – | – | |
| Dec 2022 | $53,102 | Grant | – | – | |
| Jul 2022 | $8.14M | Grant | – | – | |
| Sep 2021 | $132,474 | Grant | – | – | |
| Sep 2021 | $302,937 | Grant | – | – | |
| Jun 2021 | $975,656 | Grant | – | – | |
| May 2021 | $18,356 | Grant | – | – | |
| May 2021 | $48,824 | Grant | – | – |
4 investors in total: 4 institutional.
Investors in Merck
Merck has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include European Union, BMBF and Ministry of Economy, Finance and Industrial and Digital Sovereignty.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| economie.gouv.fr | ||||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Education and research policies are overseen by the ministry. | 1955 | bmbf.de | Berlin, Germany | |
Administers health care and support for military personnel and operations. | health.mil | Falls Church, United States |
Investor details for Merck
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Merck
The boards of the 3 registered companies of Merck currently have 6 directors; the longest-serving is Pratima Kodathala Reddy, appointed in 2022. 63 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pratima Kodathala Reddy DIN 09699956 | Managing Director | 16 Aug 2022 | 4 yrs 2 mo | Merck Specialities Private Limited |
| Suneela Milind Thatte DIN 02621328 | Director | 30 Jun 2023 | 3 yrs 4 mo | Merck Specialities Private Limited |
| Dhananjay Singh DIN 10039970 | Managing Director | 01 Apr 2024 | 2 yrs 7 mo | Merck Life Science Private Limited |
| Abhishek Kumar Agrawal DIN 11156043 | Managing Director | 15 Jul 2025 | 1 yr 3 mo | Merck Performance Materials Private Limited |
| Ketan Bakhshi DIN 01910174 | Director | 29 Jul 2025 | 1 yr 3 mo | Merck Performance Materials Private Limited |
| Pankaj Kumar Joshi DIN 11513093 | Additional Director | 30 Jan 2026 | 9 mo | Merck Life Science Private Limited |
People of Merck
546 people are tracked at Merck (254 in leadership, 292 in team); the tracked headcount is 376.
| Name | Role | Group |
|---|---|---|
Chris Minnich | Director, Coe Devices | Leadership |
Josie Downey | General Manager And Managing Director, Merck Healthcare, Australia And New Zealand | Leadership |
Bianca Rehpenning | Director | Leadership |
Rajesh Neelakanta | Associate Director - IT Business Partner | Leadership |
Delphine Lonfat Corsat | Head Of Talent, Rewards & Analytics Healthcare Sector | Leadership |
Clorinde Lacroix Hirt | Head Of Device Quality System | Leadership |
Nitish Kumar | Head Of Customer Application , Downstream, India | Leadership |
John Lee | Managing Director, Merck Group In Taiwan | Leadership |
Pierluigi Mega | Director - Head Of Smart Process Automation | Leadership |
Daniel Hookins | Gillingham Site Director And Head Of UK Distribution | Leadership |
Theresa Schlottmann | Head Of Market Positioning In Single Use & Integrated Platform Solutions | Leadership |
Lucile Martin | HR Business Partner | Leadership |
Renaut Damien | Head Of HR Australia NZ & South East Asia | Leadership |
Benjamin Kirchner | Director / Head Of ERP Architecture & Cross-services | Leadership |
Prashant Kumar | Head Of M&s Web Channel | Leadership |
Romina Marcovici | Director - Head Of Marketing Strategy Biomonitoring | Leadership |
Laurence Carudel | Head Of Segment Marketing Communication | Leadership |
Cordelia Morcos | Head Of Talent Management Enabling Functions | Leadership |
Nuno Miguel Piedade Silverio | Market Access Director | Leadership |
Kai Zinn | Senior Vice President, Sustainability Management | Leadership |
526 more people are available in the full profile.
Complete people profiles for Merck
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Merck
Merck is a publicly listed company on the IDX with ticker symbol MERK in Indonesia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date24 Apr 1996
- Listed onNSE: MERCK
- Listed entityPT Merck Tbk
- Exchange sectorHealth technology
- ISINDE0006599905
- Share price138.05 EUR (+0.33% on the day) · 2026-10-14
- Market capitalisation59,825,438,190.00 EUR
- Price to earnings25.3
- EPS (diluted, trailing year)5.45 EUR
- Dividend yield1.59%
- Volume (last session)7,009
Financials of Merck
Figures of Merck Performance Materials Private Limited, the primary company behind Merck, for FY 2025. Revenue was ₹184 Cr (-1% year on year). Net profit was ₹6.66 Cr (4% margin). EBITDA was ₹13.58 Cr (7% margin). Revenue has grown at a compounded annual rate of +7% over three years and +8% over five years.
- ₹184 CrRevenue · FY 2025 · -1% YoY
- ₹6.66 CrNet profit · 4% margin
- ₹13.58 CrEBITDA · 7% margin
- ₹2.49 CrPaid-up capital
- 48Employees (provident fund records)
- +7%Revenue CAGR, 3 years
- +8%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 21.10B EUR | 2.61B EUR | 5.95B EUR |
| 2024 | 21.16B EUR | 2.78B EUR | 6.17B EUR |
| 2023 | 20.99B EUR | 2.82B EUR | 5.83B EUR |
| 2022 | 22.23B EUR | 3.33B EUR | 6.79B EUR |
| 2021 | 19.69B EUR | 3.06B EUR | 5.99B EUR |
Balance sheet, profit and loss, cash flow and ratios of Merck Performance Materials Private Limited are on its company page.
Detailed financial statements for Merck
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Merck
Merck has strategically engaged in corporate development activities, having acquired 18 companies. Notable acquisitions include AmpTec, Ares Serono and Azem.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of biotech reagents, instruments and clinical diagnostic products | bio-techne.com | Minneapolis, United States | 1981 | Jun 2026 | •••• | |
Small molecule therapeutics are developed for cancer and rare diseases. | springworkstx.com | New York, United States | 2017 | Apr 2025 | $3.9B | |
Patient-derived organoid technology is provided for drug development services. | huborganoids.nl | Netherlands | 0 | Dec 2024 | •••• | |
Semiconductor metrology and inspection equipment is manufactured for advanced applications. | unity-sc.com | Grenoble, France | 2016 | Jul 2024 | $167.96M | |
Microbioreactors for research purposes are manufactured by Erbi Bio. | erbi-bio.com | Stoneham, United States | 2016 | Dec 2022 | •••• | |
Small-batch liposomal and pegylated formulations are developed and manufactured. | exeleadbiopharma.com | Indianapolis, United States | 2016 | Jan 2022 | $780M | |
Drugs for rare neurological diseases are developed and repurposed. | chordtherapeutics.com | 2014 | Dec 2021 | •••• | ||
Provider of products for RNA biology | amp-tec.com | Hamburg, Germany | 2005 | Jan 2021 | •••• | |
Materials development consulting is offered for semiconductor and electronics sectors. | intermolecular.com | San Jose, United States | 2004 | May 2019 | •••• | |
Web-based software for beauty salon appointment management is offered. | versum.com | Bielsko-biala, Poland | 2008 | Apr 2019 | •••• |
Complete acquisition details for Merck
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Merck
13 dated milestones of Merck across 30 years, from founding to its latest funding, stage changes and deals.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $11K.
- Acquisition Acquires Versum.
- Acquisition Acquires Intermolecular.
- Acquisition Acquires AmpTec.
- Acquisition Acquires Chord Therapeutics.
- Acquisition Acquires Exelead.
- Acquisition Acquires Erbi Bio.
- Funding Latest funding round, Grant, of $271K.
- Acquisition Acquires UnitySC.
- Acquisition Acquires Huborganoids.
- Acquisition Acquires SpringWorks Therapeutics.
- Acquisition Acquires Bio-Techne.
Web traffic of Merck
The website of Merck (merckgroup.com) receives about 910.8K visits a month and ranks #54,804 among all websites worldwide, #1,438 in Biotechnology and Pharmaceuticals.
- Monthly visits910.8K
▲ 8.3% vs previous month
- Unique visitors245.6K
per month
- Global rank#54,804
among all websites
- Category rank#1,438
Health · Biotechnology and Pharmaceuticals
- Bounce rate38%
- Pages per visit5.0
- Average visit5 min 10 sec
- DevicesDesktop 68% · Mobile 32%
Websites whose visitors overlap most with Merck. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| merck.com | 100% | 656.8K | #78,842 | View details | |
emdgroup.com | emdgroup.com | 71% | #257,460 | – | |
| novartis.com | 66% | 948.8K | #58,822 | View details | |
| medpace.com | 65% | 240.7K | #213,697 | View details | |
| bayer.com | 63% | 1.1M | #52,188 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 30 similar websites and full traffic analytics for Merck
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 30 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Merck
Complete news archive for Merck
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Merck
Merck was founded in 1668 and raised its 1st funding round 346 years after it was founded.
Merck is headquartered in Darmstadt, Germany. It is registered at Darmstadt, Hesse, Germany.
Merck has 376 employees.
Annual revenue of Merck is $21.98B as on Dec 31, 2024.
Merck is recognized as a leader in science and technology, focusing on Electronics, Healthcare, and Life Science sectors. Solutions are developed to address major illnesses, advance technological innovations, and support scientific research. Operations are conducted across 65 countries, with efforts centered on sustainability and digitalization. Partnerships and internal innovations are prioritized to elevate humanity and create a healthier future.
Merck offers Life Science Solutions, Healthcare Solutions, and Electronics Materials.
Yes, Merck is publicly traded on IDX under the ticker symbol MERK.
Merck has made 18 acquisitions, including AmpTec, Ares Serono, and Azem.
Merck has 4 investors. Key investors include European Union, BMBF, Ministry of Economy, Finance and Industrial and Digital Sovereignty, and Military Health.
Merck is associated with 3 legal entities: Merck Performance Materials Private Limited, Merck Specialities Private Limited, Merck Life Science Private Limited.
The legal entities of Merck currently have 7 directors, including Ketan Bakhshi, Abhishek Kumar Agrawal, Pratima Kodathala Reddy and others.
The website of Merck receives about 911 thousand visits a month and ranks #54,804 among all websites worldwide.